Cys-loop receptors: New twists and turns

Trends in Neurosciences

Volumn 27, Issue 6, 2004, Pages 329-336

  Lester, Henry A ^a   Dibas, Mohammed I ^a   Dahan, David S ^b   Leite, John F ^a,b   Dougherty, Dennis A ^b  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b California Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CHOLINERGIC RECEPTOR; CYSTEINE DERIVATIVE; MEMBRANE PROTEIN; NICOTINIC RECEPTOR; PROTEIN DERIVATIVE;

BINDING SITE; CATION TRANSPORT; CHANNEL GATING; CORRELATION ANALYSIS; CROSS LINKING; CRYSTAL STRUCTURE; DATA ANALYSIS; DESENSITIZATION; GENE MUTATION; ION CURRENT; LIGAND BINDING; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MOLECULAR MODEL; NEUROTRANSMISSION; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTON TRANSPORT; REVIEW; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; SYNAPSE;

ANIMALS; BINDING SITES; CATIONS; CYSTEINE; HUMANS; ION CHANNEL GATING; LIGANDS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, NICOTINIC; SEQUENCE ALIGNMENT; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 2542432136     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2004.04.002     Document Type: Review

References (93)

1. Brejc K., et al. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature. 411:2001;269-276
2. Li L., et al. The tethered agonist approach to mapping ion channel proteins - toward a structural model for the agonist binding site of the nicotinic acetylcholine receptor. Chem. Biol. 8:2001;47-58
3. 3A) and nicotinic acetylcholine receptors: the anomalous binding properties of nicotine. Biochemistry. 41:2002;10262-10269
4. Mu T.W., et al. Different binding orientations for the same agonist at homologous receptors: a lock and key or a simple wedge? J. Am. Chem. Soc. 125:2003;6850-6851
5. Miyazawa A., et al. Structure and gating mechanism of the acetylcholine receptor pore. Nature. 424:2003;949-955
6. Dougherty, D.A. and Lester, H.A. (2001) Neurobiology. Snails, synapses and smokers. Nature 411, 252-253, 255.
7. Sine S.M. The nicotinic receptor ligand binding domain. J. Neurobiol. 53:2002;431-446
8. Grutter T., Changeux J.P. Nicotinic receptors in wonderland. Trends Biochem. Sci. 26:2001;459-463
9. 2+-binding sites. Proc. Natl. Acad. Sci. U. S. A. 99:2002;3210-3215
10. Harel M., et al. The binding site of acetylcholine receptor as visualized in the X-ray structure of a complex between α-bungarotoxin and a mimotope peptide. Neuron. 32:2001;265-275
11. Czajkowski C., et al. Negatively charged amino acid residues in the nicotinic receptor δ subunit that contribute to the binding of acetylcholine. Proc. Natl. Acad. Sci. U. S. A. 90:1993;6285-6289
12. Corringer P.J., et al. Identification of a new component of the agonist binding site of the nicotinic α7 homooligomeric receptor. J. Biol. Chem. 270:1995;11749-11752
13. Sine S.M., et al. Lysine scanning mutagenesis delineates structural model of the nicotinic receptor ligand binding domain. J. Biol. Chem. 277:2002;29210-29223
14. A receptor. Nature. 421:2003;272-275
15. Chiara D.C., et al. Identification of amino acids in the nicotinic acetylcholine receptor agonist binding site and ion channel photolabeled by 4-[(3-trifluoromethyl)-3H-diazirin-3-yl]benzoylcholine, a novel photoaffinity antagonist. Biochemistry. 42:2003;271-283
16. 3H]Ro15-4513. J. Biol. Chem. 277:2002;50036-50045
17. Moise L., et al. NMR structural analysis of α-bungarotoxin and its complex with the principal α-neurotoxin-binding sequence on the α7 subunit of a neuronal nicotinic acetylcholine receptor. J. Biol. Chem. 277:2002;12406-12417
18. Sixma T.K., Smit A.B. Acetylcholine binding protein (AChBP): a secreted glial protein that provides a high-resolution model for the extracellular domain of pentameric ligand-gated ion channels. Annu. Rev. Biophys. Biomol. Struct. 32:2003;311-334
19. Sheridan R.E., Lester H.A. Functional stoichiometry at the nicotinic receptor. The photon cross-section for phase 1 corresponds to two Bis-Q molecules per channel. J. Gen. Physiol. 80:1982;499-515
20. C receptor. Nat. Neurosci. 2:1999;219-225
21. Unwin N. Acetylcholine receptor channel imaged in the open state. Nature. 373:1995;37-43
22. Unwin N., et al. Activation of the nicotinic acetylcholine receptor involves a switch in conformation of the α subunits. J. Mol. Biol. 319:2002;1165-1176
23. Wagner D.A., Czajkowski C. Structure and dynamics of the GABA binding pocket: a narrowing cleft that constricts during activation. J. Neurosci. 21:2001;67-74
24. Zhong W., et al. From ab initio quantum mechanics to molecular neurobiology: a cation-π binding site in the nicotinic receptor. Proc. Natl. Acad. Sci. U. S. A. 95:1998;12088-12093
25. Silman I., Karlin A. Acetylcholine receptor: covalent attachment of depolarizing groups at the active site. Science. 164:1969;1420-1421
26. Bartels E., et al. Photochromic activators of the acetylcholine receptor. Proc. Natl. Acad. Sci. U. S. A. 68:1971;1820-1823
27. Chabala L.D., Lester H.A. Activation of acetylcholine receptor channels by covalently bound agonists in cultured rat myoballs. J. Physiol. 379:1986;83-108
28. Sullivan D.A., Cohen J.B. Mapping the agonist binding site of the nicotinic acetylcholine receptor. Orientation requirements for activation by covalent agonist. J. Biol. Chem. 275:2000;12651-12660
29. a at the binding site of the nicotinic acetylcholine receptor: implications for nicotine binding. J. Am. Chem. Soc. 124:2002;12662-12663
30. Celie P.H.N., et al. Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures. Neuron. 41:2004;907-914
31. Schapira M., et al. Structural model of nicotinic acetylcholine receptor isotypes bound to acetylcholine and nicotine. BMC Struct. Biol. 2:2002;1
32. 3 receptor agonist-binding residues using homology modeling. Biophys. J. 84:2003;2338-2344
33. England P.M., et al. Backbone mutations in transmembrane domains of a ligand-gated ion channel: implications for the mechanism of gating. Cell. 96:1999;89-98
34. 3 receptor gating. Mol. Pharmacol. 57:2000;1114-1122
35. A receptor M2-M3 loop secondary structure and changes in accessibility during channel gating. J. Biol. Chem. 277:2002;43002-43010
36. Wick M.J., et al. Mutations of γ-aminobutyric acid and glycine receptors change alcohol cutoff: evidence for an alcohol receptor? Proc. Natl. Acad. Sci. U. S. A. 95:1998;6504-6509
37. Karlin A., Akabas M.H. Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron. 15:1995;1231-1244
38. Wilson G.G., Karlin A. The location of the gate in the acetylcholine receptor channel. Neuron. 20:1998;1269-1281
39. Karlin A. Emerging structure of the nicotinic acetylcholine receptors. Nat. Rev. Neurosci. 3:2002;102-114
40. Akabas M.H., et al. Acetylcholine receptor channel structure probed in cysteine-substitution mutants. Science. 258:1992;307-310
41. A receptor pore-lining M2 segment. Nat. Neurosci. 4:2001;477-485
42. Leite J.F., et al. Conformation-dependent hydrophobic photolabeling of the nicotinic receptor: electrophysiology-coordinated photochemistry and mass spectrometry. Proc. Natl. Acad. Sci. U. S. A. 100:2003;13054-13059
43. Lynch J.W., et al. Identification of intracellular and extracellular domains mediating signal transduction in the inhibitory glycine receptor chloride channel. EMBO J. 16:1997;110-120
44. Lewis T.M., et al. Properties of human glycine receptors containing the hyperekplexia mutation α1K276E, expressed in Xenopus oocytes. J. Physiol. 507:1998;25-40
45. Shan Q., et al. Asymmetric contribution of α and β subunits to the activation of αβ heteromeric glycine receptors. J. Neurochem. 86:2003;498-507
46. Rovira J.C., et al. Gating of α3β4 neuronal nicotinic receptor can be controlled by the loop M2-M3 of both alpha3 and beta4 subunits. Pflugers Arch. 439:1999;86-92
47. Rovira J.C., et al. A residue in the middle of the M2-M3 loop of the β4 subunit specifically affects gating of neuronal nicotinic receptors. FEBS Lett. 433:1998;89-92
48. Campos-Caro A., et al. A single residue in the M2-M3 loop is a major determinant of coupling between binding and gating in neuronal nicotinic receptors. Proc. Natl. Acad. Sci. U. S. A. 93:1996;6118-6123
49. Deane C.M., Lummis S.C. The role and predicted propensity of conserved proline residues in the 5-HT3 receptor. J. Biol. Chem. 276:2001;37962-37966
50. A receptor. J. Neurochem. 73:1999;1758-1764
51. Kusama T., et al. Mutagenesis of the GABA ρ1 receptor alters agonist affinity and channel gating. NeuroReport. 5:1994;1209-1212
52. A receptor α1 subunit reveals a domain that affects sensitivity to GABA and benzodiazepine-site ligands. J. Neurochem. 79:2001;55-62
53. O'Shea S.M., Harrison N.L. Arg-274 and Leu-277 of the γ-aminobutyric acid type A receptor α2 subunit define agonist efficacy and potency. J. Biol. Chem. 275:2000;22764-22768
54. Lynch J.W., et al. The surface accessibility of the glycine receptor M2-M3 loop is increased in the channel open state. J. Neurosci. 21:2001;2589-2599
55. Croxen R., et al. Mutations in different functional domains of the human muscle acetylcholine receptor α subunit in patients with the slow-channel congenital myasthenic syndrome. Hum. Mol. Genet. 6:1997;767-774
56. Grosman C., et al. The extracellular linker of muscle acetylcholine receptor channels is a gating control element. J. Gen. Physiol. 116:2000;327-340
57. Dang H., et al. Membrane-buried proline residue is a key element in the gating of α7 nicotinic receptor. Soc. Neurosci. Abstr. 21:1995;343
58. England P.M., et al. Site-specific, photochemical proteolysis applied to ion channels in vivo. Proc. Natl. Acad. Sci. U. S. A. 94:1997;11025-11030
59. Lyford L.K., et al. Agonist-induced conformational changes in the extracellular domain of α7 nicotinic acetylcholine receptors. Mol. Pharmacol. 64:2003;650-658
60. Akabas M.H., Karlin A. Identification of acetylcholine receptor channel-lining residues in the M1 segment of the β-subunit. Biochemistry. 34:1995;12496-12500
61. Zhang H., Karlin A. Identification of acetylcholine receptor channel-lining residues in the M1 segment of the β-subunit. Biochemistry. 36:1997;15856-15864
62. Grosman C., et al. Mapping the conformational wave of acetylcholine receptor channel gating. Nature. 403:2000;773-776
63. Cymes G.D., et al. Structure of the transition state of gating in the acetylcholine receptor channel pore: a Φ-value analysis. Biochemistry. 41:2002;5548-5555
64. Dahan, D., et al. A fluorophore attached to nicotinic acetylcholine receptor βM2 detects agonist binding to the αδ site. Proc. Natl. Acad. Sci. U. S. A. (in press).
65. Keramidas, A., et al. Ligand-gated ion channels: mechanisms underlying ion selectivity. Prog. Biophys. Mol. Biol. (in press).
66. Miyazawa A., et al. Nicotinic acetylcholine receptor at 4.6 Å resolution: transverse tunnels in the channel wall. J. Mol. Biol. 288:1999;765-786
67. Finer-Moore J., Stroud R.M. Amphipathic analysis and possible formation of the ion channel in an acetylcholine receptor. Proc. Natl. Acad. Sci. U. S. A. 81:1984;155-159
68. 3 receptors. Nature. 424:2003;321-324
69. Nakazawa K. ATP-activated current and its interaction with acetylcholine-activated current in rat sympathetic neurons. J. Neurosci. 14:1994;740-750
70. Searl T.J., et al. Mutual occlusion of P2X ATP receptors and nicotinic receptors on sympathetic neurons of the guinea-pig. J. Physiol. 510:1998;783-791
71. Zhou X., Galligan J.J. Non-additive interaction between nicotinic cholinergic and P2X purine receptors in guinea-pig enteric neurons in culture. J. Physiol. 513:1998;685-697
72. Barajas-Lopez C., et al. Functional interactions between nicotinic and P2X channels in short-term cultures of guinea-pig submucosal neurons. J. Physiol. 513:1998;671-683
73. Khakh B.S., et al. State-dependent cross-inhibition between transmitter-gated cation channels. Nature. 406:2000;405-410
74. Khakh B.S., et al. Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds. Nat. Neurosci. 2:1999;322-330
75. Virginio C., et al. Pore dilation of neuronal P2X receptor channels. Nat. Neurosci. 2:1999;315-321
76. Boue-Grabot E., et al. Intracellular cross talk and physical interaction between two classes of neurotransmitter-gated channels. J. Neurosci. 23:2003;1246-1253
77. Chimienti F., et al. Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda. Hum. Mol. Genet. 12:2003;3017-3024
78. Ibanez-Tallon I., et al. Novel modulation of neuronal nicotinic acetylcholine receptors by association with the endogenous prototoxin lynx1. Neuron. 33:2002;893-903
79. Miwa J.M., et al. lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine receptors in the mammalian CNS. Neuron. 23:1999;105-114
80. Hall Z.W. α neurotoxins and their relatives: foes and friends? Neuron. 23:1999;4-5
81. Chakrapani S., et al. The role of loop 5 in acetylcholine receptor channel gating. J. Gen. Physiol. 122:2003;521-539
82. Beg A.A., Jorgensen E.M. EXP-1 is an excitatory GABA-gated cation channel. Nat. Neurosci. 6:2003;1145-1152
83. Simosky J.K., et al. Nicotinic agonists and psychosis. Curr. Drug Target CNS Neurol Disord. 1:2002;149-162
84. Samochocki M., et al. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 305:2003;1024-1036
85. Bannon A.W., et al. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science. 279:1998;77-81
86. Tanner C.M., et al. Smoking and Parkinson's disease in twins. Neurology. 58:2002;581-588
87. Levin E.D., et al. Transdermal nicotine effects on attention. Psychopharmacology. 140:1998;135-141
88. Shytle R.D., et al. A pilot controlled trial of transdermal nicotine in the treatment of attention deficit hyperactivity disorder. World J. Biol. Psychiatry. 3:2002;150-155
89. Bonapace C.R., Mays D.A. The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease. Ann. Pharmacother. 31:1997;907-913
90. Willoughby J.O., et al. Nicotine as an antiepileptic agent in ADNFLE: an N-of-one study. Epilepsia. 44:2003;1238-1240
91. Lippiello P.M., et al. RJR-2403: a nicotinic agonist with CNS selectivity II. In vivo characterization. J. Pharmacol. Exp. Ther. 279:1996;1422-1429
92. A receptor mutation. Brain. 126:2003;230-240
93. A receptor gene family: new opportunities for drug development. Curr. Opin. Drug Discov. Dev. 6:2003;648-657